Alterations in cholesterol metabolism-related genes in sporadic Alzheimer ’s disease
Genome-wide association studies have identified several cholesterol metabolism-related genes as top risk factors for late-onset Alzheimer ’s disease (LOAD). We hypothesized that specific genetic variants could act as disease-modifying factors by altering the expression of those genes. Targeted association studies were conducted with available genomic, transcriptomic, proteomic and histopathological data from three independent cohort s: the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the Quebec Founder Population (QFP) and the United Kingdom Brain Expression Consortium (UKBEC).
Source: Neurobiology of Aging - Category: Neuroscience Authors: Cynthia Picard, C édric Julien, Josée Frappier, Justin Miron, Louise Théroux, Doris Dea, United Kingdom Brain Expression Consortium and for the Alzheimer’s Disease Neuroimaging Initiative, John C.S. Breitner, Judes Poirier Source Type: research
More News: Alzheimer's | Brain | Cholesterol | Genetics | Neurology | Neuroscience | Study | UK Health